BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 10227332)

  • 1. Utilization and cost of immunotherapy for allergic asthma and rhinitis.
    Donahue JG; Greineder DK; Connor-Lacke L; Canning CF; Platt R
    Ann Allergy Asthma Immunol; 1999 Apr; 82(4):339-47. PubMed ID: 10227332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study.
    Hankin CS; Cox L; Lang D; Bronstone A; Fass P; Leatherman B; Wang Z
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):79-85. PubMed ID: 20143650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma.
    Brüggenjürgen B; Reinhold T; Brehler R; Laake E; Wiese G; Machate U; Willich SN
    Ann Allergy Asthma Immunol; 2008 Sep; 101(3):316-24. PubMed ID: 18814456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs.
    Hankin CS; Cox L; Lang D; Levin A; Gross G; Eavy G; Meltzer E; Burgoyne D; Bronstone A; Wang Z
    J Allergy Clin Immunol; 2008 Jan; 121(1):227-32. PubMed ID: 18206509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France.
    Omnes LF; Bousquet J; Scheinmann P; Neukirch F; Jasso-Mosqueda G; Chicoye A; Champion L; Fadel R
    Eur Ann Allergy Clin Immunol; 2007 May; 39(5):148-56. PubMed ID: 17626329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma.
    Berto P; Bassi M; Incorvaia C; Frati F; Puccinelli P; Giaquinto C; Cantarutti L; Ortolani C
    Eur Ann Allergy Clin Immunol; 2005 Oct; 37(8):303-8. PubMed ID: 17066648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children multicenter trial.
    Acquistapace F; Agostinis F; Castella V; Kantar A; Novembre E; Perrone MR; Pietrasanta M; Sambugaro R; Milani M
    Pediatr Allergy Immunol; 2009 Nov; 20(7):660-4. PubMed ID: 19320852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma.
    Nasser S; Vestenbaek U; Beriot-Mathiot A; Poulsen PB
    Allergy; 2008 Dec; 63(12):1624-9. PubMed ID: 19032235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis.
    Thomas M; Kocevar VS; Zhang Q; Yin DD; Price D
    Pediatrics; 2005 Jan; 115(1):129-34. PubMed ID: 15629992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
    Ibáñez Sendín MD
    Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunotherapy of allergic disease. Studies on 460 patients].
    Jarisch R; Sandor I; Götz M; Kummer F
    Hautarzt; 1979 Jul; 30(7):365-70. PubMed ID: 478857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of allergen immunotherapy on soluble adhesion molecules.
    Pereira-Santos MC; Pregal AL; Spínola-Santos A; Alonso E; Palma-Carlos ML; Palma-Carlos AG
    Allerg Immunol (Paris); 2001 Jun; 33(6):225-8. PubMed ID: 11505805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of allergen immunotherapy in the treatment of allergic rhinitis and asthma in real life.
    Zeldin Y; Weiler Z; Magen E; Tiosano L; Kidon MI
    Isr Med Assoc J; 2008 Dec; 10(12):869-72. PubMed ID: 19160945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Willingness to pay for allergy-vaccination among Danish patients with respiratory allergy.
    Petersen KD; Gyrd-Hansen D; Linneberg A; Dahl R; Larsen JN; Løwenstein H; Kronborg C
    Int J Technol Assess Health Care; 2010 Jan; 26(1):20-9. PubMed ID: 20059777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergic rhinitis: evidence for impact on asthma.
    Thomas M
    BMC Pulm Med; 2006 Nov; 6 Suppl 1(Suppl 1):S4. PubMed ID: 17140422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhinitis and asthma co-morbidity in respiratory allergy due to house dust mite: results of an observational open controlled parallel group study in real-life setting.
    Marogna M; Spadolini I; Massolo A
    Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):135-42. PubMed ID: 15916014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate adverse reactions to immunotherapy.
    Can D; Demir E; Tanaç R; Gülen F; Yenigün A
    J Investig Allergol Clin Immunol; 2003; 13(3):177-80. PubMed ID: 14635467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical efficacy and costs of the three-year specific allergen immunotherapy--retrospective study].
    Targowski T; Jahnz-Rózyk K; Przekora P; Kucharczyk A; Owczarek W
    Pol Merkur Lekarski; 2011 Aug; 31(182):106-10. PubMed ID: 21936348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local immunotherapy in chronic allergic rhinitis and bronchial asthma with allergen aerosols. III. Dynamics of some sensitization and immunity indexes.
    Moshkevich VS; Tsarevskaya LA; Nurpeisov TN; Nugmanova JS; Tsoy VP
    Allergol Immunopathol (Madr); 1986; 14(4):277-85. PubMed ID: 3776777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.